Mesoblast | MSB - Vermögenswerte

Aktienkurs
2.02
Täglich Wechseln
0.04 1.76%
Monatlich
-4.27%
Jährlich
25.86%
Q2 Prognose
2.08




Vermögenswerte Veränderung Datum
Avita Medical AUD 56.39M 1.74M 2025-12
Clinuvel Pharmaceuticals AUD 269.7M 2.05M 2025-12
Cochlear AUD 2.79B 31.3M 2025-12
CSL USD 37.9B 1.5B 2025-12
Pacific Edge NZD 34.66M 2.37M 2025-12
Paradigm Biopharmaceuticals AUD 23.15M 1.42M 2025-12
PYC Therapeutics AUD 159.13M 24.15M 2025-12
Ramsay Health Care AUD 21.7B 777.8M 2025-12
Sonic Healthcare AUD 15.38B 550.57M 2024-12
Starpharma Holdings AUD 26.17M 746K 2025-12
Telix Pharmaceuticals AUD 1.16B 25.97M 2025-12